LRNDvsPRXGETF Comparison
NYLI U.S. Large Cap R&D Leaders ETF (LRND) belongs to the US Large Cap segment. Praxis Impact Large Cap Growth ETF (PRXG) is part of the US Large Cap Growth segment. LRND's top 3 sector exposures are Technology, Healthcare and Consumer Non-Cyclicals. In contrast, PRXG's top sector exposures are Technology, Consumer Non-Cyclicals and Finance. LRND is less expensive with a Total Expense Ratio (TER) of 0.15%, versus 0.36% for PRXG. LRND is up 13.84% year-to-date (YTD) with +$328M in YTD flows. PRXG performs worse with 9.22% YTD performance, and +$11M in YTD flows. Run a side-by-side ETF comparison of LRND and PRXG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LRND vs PRXG performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LRND PRXG | -1.45%-0.65% | +5.87%+3.88% | +13.84%+9.22% | +19.35%+13.74% | +79.29%n/a | n/an/a |
| Flows | LRND PRXG | +$35M+$2M | +$93M+$2M | +$328M+$11M | +$387M+$30M | +$387M- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LRND PRXG | +16.71%+17.03% | +16.90%+17.40% | +17.77%n/a | n/an/a |
| Max drawdown | LRND PRXG | -4.90%-6.22% | -13.88%-15.94% | -20.97%n/a | n/an/a |
| Max drawdown duration | LRND PRXG | 23d19d | 169d177d | 126dn/a | n/an/a |
LRND | PRXG | |
Last sale 9/11/2026 at 1:30 PM | $46.30 | $39.86 |
| Previous close 09/10/2026 | $45.80 | $39.48 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LRND | PRXG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LRND | PRXG | |
|---|---|---|
| Last price | $46.30 | $39.86 |
| 1D performance | +1.09% | +0.95% |
| AuM | $445.53 M | $89.62 M |
| E/R | 0.15% | 0.36% |
LRND | PRXG | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | New York Life Investments | Praxis |
| Benchmark | NYLI U.S. Large Cap R&D Leaders Index | CRSP U.S. Large Cap Growth Index |
| N° of holdings | 520 | 144 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 8, 2022 | April 7, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
